CYP1A2 and cancer: Elevated in vivo expression of CYP1A2 has been postulated as a risk factor for cancers affecting the bladder, colon, and rectum, where exposure to substances like aromatic amines and heterocyclic amines (HAs) has been implicated in the etiology of the disease [10, 11].